Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
210, P. 107532 - 107532
Published: Dec. 1, 2024
Protein
post
translational
modification
(PTM)
is
the
main
regulatory
mechanism
for
eukaryotic
cell
function,
among
which
ubiquitination
based
on
reversible
degradation
of
proteins
by
ubiquitin
proteasome
system
to
regulate
homeostasis.
The
neural
precursor
expressed
developmental
downregulated
gene
8
(NEDD8)
a
kind
like
protein
that
shares
80
%
homology
and
60
identity
with
ubiquitin.
PTM
process
covalently
binding
NEDD8
lysine
residues
in
called
neddylation.
neddylation
reaction
could
be
regulated
NEDD8,
its
precursors,
substrates,
E1
activating
enzymes,
E2
E3
ligases,
de-neddylases,
inhibitors,
such
as
MLN4924.
widely
whole
structure
multiple
tissues
species,
related
factors
are
highly
metabolism
adrenal
glands,
thyroid
parathyroid
skeletal
muscles,
myocardium,
adipose
tissues,
metabolic
cardiovascular,
cerebrovascular
liver
diseases,
adipogenic
osteogenic
differentiation,
well
tumor
glycolysis
glucose
resulting
from
angiogenesis
endothelial
disfunction,
hepatotoxicity,
adipogenesis,
osteogenesis,
Warburg
effect,
insulin
function.
This
review
provides
researchers
new
approach
explore
diseases
via
searching
analyzing
histological,
cytological,
subcellular
localization
specific
molecules
databases,
exploring
mediating
terms
development
pre-clinical
pharmacological
inhibitors.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: April 4, 2024
Abstract
NEDD8
(Neural
precursor
cell
expressed
developmentally
downregulated
protein
8)
is
an
ubiquitin-like
that
covalently
attached
to
a
lysine
residue
of
substrate
through
process
known
as
neddylation,
catalyzed
by
the
enzyme
cascade,
namely
activating
(E1),
conjugating
(E2),
and
ligase
(E3).
The
substrates
neddylation
are
categorized
into
cullins
non-cullin
proteins.
Neddylation
activates
CRLs
(cullin
RING
ligases),
largest
family
E3
ligases,
whereas
alters
their
stability
activity,
well
subcellular
localization.
Significantly,
pathway
and/or
many
abnormally
activated
or
over-expressed
in
various
human
diseases,
such
metabolic
disorders,
liver
dysfunction,
neurodegenerative
cancers,
among
others.
Thus,
targeting
becomes
attractive
strategy
for
treatment
these
diseases.
In
this
review,
we
first
provide
general
introduction
on
its
biochemical
regulation,
crystal
structures
enzymes
complex
with
cullin
substrates;
then
discuss
how
governs
key
biological
processes
via
modification
substrates.
We
further
review
literature
data
dysregulated
several
particularly
cancer,
followed
outline
current
efforts
discovery
small
molecule
inhibitors
promising
therapeutic
approach.
Finally,
few
perspectives
were
proposed
extensive
future
investigations.
Life,
Journal Year:
2025,
Volume and Issue:
15(1), P. 126 - 126
Published: Jan. 18, 2025
Post-translational
modifications
(PTMs)
of
proteins
dynamically
build
the
buffering
and
adapting
interface
between
oncogenic
mutations
environmental
stressors,
on
one
hand,
cancer
cell
structure,
functioning,
behavior.
Aberrant
PTMs
can
be
considered
as
enabling
characteristics
long
they
orchestrate
all
malignant
variability
in
proteome
cells,
cancer-associated
tumor
microenvironment
(TME).
On
other
enhance
anticancer
mechanisms
tumoral
ecosystem
or
sustain
beneficial
effects
oncologic
therapies
through
degradation
inactivation
carcinogenic
or/and
activation
tumor-suppressor
proteins.
In
this
review,
we
summarized
analyzed
a
wide
spectrum
involved
regulatory
that
drive
tumorigenesis,
genetic
instability,
epigenetic
reprogramming,
events
metastatic
cascade,
cytoskeleton
extracellular
matrix
(ECM)
remodeling,
angiogenesis,
immune
response,
tumor-associated
microbiome,
metabolism
rewiring
most
important
hallmarks
cancer.
All
develop
due
to
proteins,
which
modulate
gene
transcription,
intracellular
signaling,
protein
size,
activity,
stability
localization,
trafficking,
secretion,
half-life,
protein–protein
interactions
(PPIs).
associated
with
exploited
better
understand
underlying
molecular
heterogeneous
chameleonic
disease,
find
new
biomarkers
progression
prognosis,
personalize
oncotherapies,
discover
targets
for
drug
development.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(17), P. 4280 - 4280
Published: Sept. 9, 2024
In
this
review
we
explore
innovative
approaches
in
the
treatment
of
hematologic
cancers
by
combining
various
therapeutic
modalities.
We
discuss
synergistic
potential
inhibitors
targeting
different
cellular
pathways
with
immunotherapies,
molecular
therapies,
and
hormonal
therapies.
Examples
include
PI3K
proteasome
inhibitors,
NF-κB
immunotherapy
checkpoint
neddylation
therapies
tumor
microenvironment.
Additionally,
use
small
molecules
peptide
cancer
treatment.
These
multidimensional
combinations
present
promising
strategies
for
enhancing
efficacy
overcoming
resistance
mechanisms.
However,
further
clinical
research
is
required
to
validate
their
effectiveness
safety
profiles
patients.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(5), P. 635 - 635
Published: May 15, 2024
Background:
Neddylation,
a
post-translational
modification
process,
plays
crucial
role
in
various
human
neoplasms.
However,
its
connection
with
kidney
renal
clear
cell
carcinoma
(KIRC)
remains
under-researched.
Methods:
We
validated
the
Gene
Set
Cancer
Analysis
Lite
(GSCALite)
platform
against
The
Genome
Atlas
(TCGA)
database,
analyzing
33
cancer
types
and
their
link
17
neddylation-related
genes.
This
included
examining
copy
number
variations
(CNVs),
single
nucleotide
(SNVs),
mRNA
expression,
cellular
pathway
involvement,
methylation.
Using
Variation
(GSVA),
we
categorized
these
genes
into
three
clusters
examined
impact
on
KIRC
patient
prognosis,
drug
responses,
immune
infiltration,
oncogenic
pathways.
Afterward,
our
objective
is
to
identify
that
exhibit
overexpression
are
associated
an
adverse
prognosis.
After
pinpointing
specific
target
gene,
used
inhibitor
MLN4924
inhibit
neddylation
conduct
RNA
sequencing
related
vitro
experiments
verify
study
specificity
potential
mechanisms
target.
approach
geared
towards
enhancing
understanding
of
prognostic
importance
KIRC.
Results:
identified
significant
CNV,
SNV,
methylation
events
across
cancers,
notably
higher
expression
levels
observed
Cluster
analysis
revealed
trade-off
interactions
among
genes,
where
both
high
low
gene
linked
prognoses.
association
particularly
pronounced
concerning
lymph
node
T
stage
classification,
Fustat
score.
Simultaneously,
research
discovered
PSMB10
exhibits
when
compared
normal
tissues,
negatively
impacting
Through
assays,
confirmed
inhibition
could
play
regulation
signaling
pathways,
thereby
influencing
prognosis
Moreover,
results
underscore
as
viable
for
therapeutic
intervention
KIRC,
opening
up
novel
pathways
development
targeted
treatment
strategies.
Conclusion:
underscores
regulatory
function
mechanism
phenotype
identifying
key
International Immunopharmacology,
Journal Year:
2024,
Volume and Issue:
139, P. 112716 - 112716
Published: July 21, 2024
Prolonged
exposure
to
interleukin-17A
(IL-17A)
can
induce
autoimmune
myocarditis,
and
MLN4924,
an
inhibitor
of
NEDD8
activating
enzyme
(NAE),
has
been
reported
effectively
suppress
various
inflammatory
reactions.
However,
the
effects
MLN4924
in
IL-17A-mediated
inflammation
associated
with
myocarditis
remain
uncertain.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 8, 2024
Abstract
Background
Glioma
is
the
most
prevalent
malignant
tumor
that
originates
from
central
nervous
system.
Neddylation,
a
post-translational
modification
similar
to
ubiquitination,
involved
in
tumorigenesis
and
progression.
However,
there
were
limited
studies
focused
on
neddylation
glioma.
Therefore,
we
aimed
explore
potential
role
of
Methods
In
this
study,
neddylation-related
genes
(NRGs)
identified
used
construct
prognostic
signature
for
glioma
patients.
Based
index,
also
explored
differences
clinical
features,
mutational
landscape,
immune
cell
infiltration
between
high-risk
low-risk
groups.
Next,
single-cell
RNA
sequencing
analysis
was
further
performed
verify
expression
these
NRG
signature.
At
last,
one
gene
selected
validated
by
vitro
experiments.
Results
Seven
(TOP2A,
F2R,
UST,
HSPA1B,
LGALS3BP,
UROS,
OSBPL11)
signature,
which
able
successfully
classify
patients
into
A
nomogram
based
other
factors
developed
accurately
predict
prognosis
Significant
prognosis,
found
distinct
Moreover,
experiments
illustrated
knockdown
HSPA1B
could
inhibit
proliferation,
migration,
invasion
cells
polarization
M2
macrophages.
Conclusion
These
findings
provide
new
insights
understanding
relationship
NRGs
development
identify
novel
biomarkers
may
help
guiding
precise
treatments